ESTRACYT Side Effects

6933817-X | Hepatic Function Abnormal
on Aug 09, 2010 Male patient from JAPAN , 83 years of age, was diagnosed with prostate cancer recurrent and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Estracyt dosage: 626.8 Mg/day. During the same period patient was treated with WARFARIN POTASSIUM (1 Mg/day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FAMOTIDINE (40 Mg/day) (View Famotidine Review and Famotidine Label ), NAFTOPIDIL (50 Mg/day) (View Naftopidil Review and Naftopidil Label ), VESICARE (5 Mg/day) (View Vesicare Review and Vesicare Label ), PRIMPERAN TAB (10 Mg/day) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6908624-4 | Hepatic Function Abnormal
Patient was taking Estracyt (View Usage). Patient had the following side effects: hepatic function abnormal on Jul 27, 2010 from JAPAN Additional patient health information: Male patient , 83 years of age, was diagnosed with prostate cancer recurrent and. Estracyt dosage: 626.8 Mg/day. During the same period patient was treated with WARFARIN POTASSIUM (1 Mg/day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FAMOTIDINE (40 Mg/day) (View Famotidine Review and Famotidine Label ), NAFTOPIDIL (50 Mg/day) (View Naftopidil Review and Naftopidil Label ), VESICARE (5 Mg/day) (View Vesicare Review and Vesicare Label ), PRIMPERAN TAB (10 Mg/day) (View Primperan Tab Review and Primperan Tab Label ). Patient was hospitalized.

6863497-3 | Pharyngeal Oedema
Adverse event was reported on Jul 09, 2010 by a Male patient taking Estracyt (View Usage) (Dosage: 313.4 Mg/day) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: JAPAN , 90 years of age, After Estracyt was administered, patient had the following side effects: pharyngeal oedema.

6847811-0 | Activated Partial Thromboplastin Time Prolonged, Blood Pressure Increased, Decreased Appetite, Oedema Peripheral
on Jul 08, 2010 Male patient from CHINA , 70 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, blood pressure increased, decreased appetite, oedema peripheral. Estracyt dosage: 0.14 G, 2x/day.


6809690-7 | Pharyngeal Oedema
on Jun 18, 2010 Male patient from JAPAN , 90 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient had the following side effects: pharyngeal oedema. Estracyt dosage: 313.4 Mg/day.

6779893-9 | Angioedema
Patient was taking Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: angioedema on Jun 10, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, . Estracyt dosage: Unk.

6770373-3 | Gastritis, Hepatic Function Abnormal, Pruritus
Adverse event was reported on Jun 04, 2010 by a Male patient taking Estracyt (View Usage) (Dosage: 626.8 Mg/day) . Location: JAPAN , 83 years of age, Patient experienced the following unwanted or unexpected effects: gastritis, hepatic function abnormal, pruritus. During the same period patient was treated with WARFARIN POTASSIUM (1 Mg/day) (View Warfarin Potassium Review and Warfarin Potassium Label ), FAMOTIDINE (40 Mg/day) (View Famotidine Review and Famotidine Label ), NAFTOPIDIL (50 Mg/day) (View Naftopidil Review and Naftopidil Label ), VESICARE (5 Mg/day) (View Vesicare Review and Vesicare Label ), PRIMPERAN (10 Mg/day) (View Primperan Review and Primperan Label ). Patient was hospitalized.

6697339-6 | Blood Pressure Increased, Cerebellar Ischaemia, Cerebral Atrophy, Cerebral Infarction, Fibrin D Dimer Increased, Heart Rate Increased, Ischaemic Stroke, Leukoencephalopathy, Vascular Dementia
on Nov 05, 2009 Male patient from FRANCE , 93 years of age, was treated with Estracyt (View Usage). Patient had the following side effects: blood pressure increased, cerebellar ischaemia, cerebral atrophy, cerebral infarction, fibrin d dimer increased, heart rate increased, ischaemic stroke, leukoencephalopathy, vascular dementia. Estracyt dosage: 280 Mg. During the same period patient was treated with SERESTA (Unk) (View Seresta Review and Seresta Label ), SPECIAFOLDINE (Unk) (View Speciafoldine Review and Speciafoldine Label ), ATHYMIL (Unk) (View Athymil Review and Athymil Label ), CODOLIPRANE (Unk) (View Codoliprane Review and Codoliprane Label ), FORLAX (Unk) (View Forlax Review and Forlax Label ), ALOPLASTINE (Unk) (View Aloplastine Review and Aloplastine Label ), UVEDOSE (Unk) (View Uvedose Review and Uvedose Label ). Patient was hospitalized.

6556540-2 | Angioedema
on Jan 20, 2010 Male patient from ITALY , 62 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension and was treated with Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: angioedema. Estracyt dosage: 6 Unit Dose X Day. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg X Day) (View Enalapril Maleate Review and Enalapril Maleate Label ), NADROPARIN CALCIUM (View Nadroparin Calcium Review and Nadroparin Calcium Label ), MODURETIC ^MERCK^ (View Moduretic ^merck^ Review and Moduretic ^merck^ Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DICLOREUM (View Dicloreum Review and Dicloreum Label ), CO EFFERALGAN (View Co-efferalgan Review and Co-efferalgan Label ). Patient was hospitalized.

6473761-8 | Angioedema
Patient was taking Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema on Nov 25, 2009 from ITALY Additional patient health information: Male patient , 62 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension and. Estracyt dosage: 6 Units Dose X Day. During the same period patient was treated with ENALAPRIL MALEATE (20 Mg X Day) (View Enalapril Maleate Review and Enalapril Maleate Label ), NADROPARIN CALCIUM (View Nadroparin Calcium Review and Nadroparin Calcium Label ), MODURETIC ^MERCK^ (View Moduretic ^merck^ Review and Moduretic ^merck^ Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DICLOREUM (View Dicloreum Review and Dicloreum Label ), CO EFFERALGAN (View Co-efferalgan Review and Co-efferalgan Label ). Patient was hospitalized.

6442111-5 | Hepatitis, Transaminases Increased
Adverse event was reported on Nov 02, 2009 by a Male patient taking Estracyt (View Usage) (Dosage: 140 Mg, 3x/day) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 84 years of age, weighting 216.1 lb, Patient had the following side effects: hepatitis (What is hepatitis?), transaminases increased. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), EBRANTIL (View Ebrantil Review and Ebrantil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DARIFENACIN (View Darifenacin Review and Darifenacin Label ), CONCOR COR (View Concor Cor Review and Concor Cor Label ). Patient was hospitalized.

6405486-9 | Hepatitis, Transaminases Increased
on Oct 09, 2009 Female patient from GERMANY , 84 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: hepatitis (What is hepatitis?), transaminases increased. Estracyt dosage: 140 Mg, 3x/day. Patient was hospitalized.

6377068-9 | Alanine Aminotransferase Increased, Hepatitis
on Sep 16, 2009 Female patient from GERMANY , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, hepatitis (What is hepatitis?). Estracyt dosage: 140 Mg, 3x/day. Patient was hospitalized.

6343906-9 | Cholelithiasis, Hepatic Necrosis, Hepatitis Toxic, Jaundice
Patient was taking Estracyt (View Usage). Patient had the following side effects: cholelithiasis, hepatic necrosis, hepatitis toxic, jaundice (What is jaundice?) on Aug 25, 2009 from ITALY Additional patient health information: Female patient , 84 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Estracyt dosage: 420 Mg, 1x/day. During the same period patient was treated with DECAPEPTYL (11.25 Mg, Unk) (View Decapeptyl Review and Decapeptyl Label ), FOSIPRES (20 Mg, Unk) (View Fosipres Review and Fosipres Label ), LORAZEPAM (2.5 Mg, Unk) (View Lorazepam Review and Lorazepam Label ), PARIET (20 Mg, Unk) (View Pariet Review and Pariet Label ), SPIRIVA (18 Ug, Unk) (View Spiriva Review and Spiriva Label ), SERETIDE (300 Ug, Unk) (View Seretide Review and Seretide Label ). Patient was hospitalized.

6299384-1 | Hepatitis Toxic, Jaundice
Adverse event was reported on Jul 27, 2009 by a Female patient taking Estracyt (View Usage) (Dosage: 420 Mg, 1x/day) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: ITALY , 84 years of age, After Estracyt was administered, patient had the following side effects: hepatitis toxic, jaundice (What is jaundice?). During the same period patient was treated with DECAPEPTYL (11.25 Mg, Unk) (View Decapeptyl Review and Decapeptyl Label ), FOSIPRES (20 Mg, Unk) (View Fosipres Review and Fosipres Label ), LORAZEPAM (2.5 Mg, Unk) (View Lorazepam Review and Lorazepam Label ), PARIET (20 Mg, Unk) (View Pariet Review and Pariet Label ), SPIRIVA (18 Ug, Unk) (View Spiriva Review and Spiriva Label ), SERETIDE (300 Ug, Unk) (View Seretide Review and Seretide Label ). Patient was hospitalized.

6264150-X | Altered State Of Consciousness, Blood Potassium Increased, Fibrin D Dimer Increased, Renal Impairment
on Jun 29, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, blood potassium increased, fibrin d dimer increased, renal impairment. Estracyt dosage: 626.8 Mg. During the same period patient was treated with VALSARTAN (40 Mg, 1x/day) (View Valsartan Review and Valsartan Label ), NAFTOPIDIL (75 Mg/day) (View Naftopidil Review and Naftopidil Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), PITAVASTATIN CALCIUM (1 Mg/day) (View Pitavastatin Calcium Review and Pitavastatin Calcium Label ). Patient was hospitalized.

6258461-1 | Blood Potassium Increased, Fibrin D Dimer Increased, Renal Impairment
on Jun 25, 2009 Female patient from JAPAN , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension and was treated with Estracyt (View Usage). Patient had the following side effects: blood potassium increased, fibrin d dimer increased, renal impairment. Estracyt dosage: 626.8 Mg. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), NAFTOPIDIL (75 Mg/day) (View Naftopidil Review and Naftopidil Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), PITAVASTATIN CALCIUM (1 Mg/day) (View Pitavastatin Calcium Review and Pitavastatin Calcium Label ).

6255887-7 | Cholelithiasis, Hepatic Necrosis, Hepatitis Toxic, Jaundice
Patient was taking Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: cholelithiasis, hepatic necrosis, hepatitis toxic, jaundice (What is jaundice?) on Jun 26, 2009 from ITALY Additional patient health information: Female patient , 84 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Estracyt dosage: 420 Mg, 1x/day. During the same period patient was treated with DECAPEPTYL (11.25 Mg, Unk) (View Decapeptyl Review and Decapeptyl Label ), FOSIPRES (20 Mg, Unk) (View Fosipres Review and Fosipres Label ), LORAZEPAM (2.5 Mg, Unk) (View Lorazepam Review and Lorazepam Label ), PARIET (20 Mg, Unk) (View Pariet Review and Pariet Label ), SPIRIVA (18 Ug, Unk) (View Spiriva Review and Spiriva Label ), SERETIDE (300 Ug, Unk) (View Seretide Review and Seretide Label ). Patient was hospitalized.

5802038-6 | Prostatic Specific Antigen Increased
Adverse event was reported on Jun 30, 2008 by a Male patient taking Estracyt (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?), urinary tract infection (What is urinary tract infection?) and. Location: BRAZIL , weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: prostatic specific antigen increased. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5675077-6 | Oedema Peripheral, Pleural Effusion
on Mar 10, 2008 Male patient from JAPAN , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient had the following side effects: oedema peripheral, pleural effusion. Estracyt dosage: . Patient was hospitalized.

5532463-2 | Interstitial Lung Disease
on Nov 22, 2007 Male patient from JAPAN , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: interstitial lung disease. Estracyt dosage: Daily Dose:156.7mg. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), LACTOMIN (View Lactomin Review and Lactomin Label ). Patient was hospitalized.

5524271-3 | Interstitial Lung Disease
Patient was taking Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Nov 09, 2007 from JAPAN Additional patient health information: Male patient , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Estracyt dosage: Daily Dose:156.7mg. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), LACTOMIN (View Lactomin Review and Lactomin Label ). Patient was hospitalized.

5520619-4 | Interstitial Lung Disease
Adverse event was reported on Nov 06, 2007 by a Male patient taking Estracyt (View Usage) (Dosage: Daily Dose:156.7mg) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: JAPAN , 83 years of age, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), LACTOMIN (View Lactomin Review and Lactomin Label ). Patient was hospitalized.

5506791-0 | Interstitial Lung Disease
on Oct 24, 2007 Male patient from JAPAN , 83 years of age, was treated with Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: interstitial lung disease. Estracyt dosage: .

5405370-3 | Subileus
on Jul 26, 2007 Male patient from FRANCE , weighting 112.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: subileus. Estracyt dosage: Text:1 Tablet-freq:daily. During the same period patient was treated with TRIPTORELIN (View Triptorelin Review and Triptorelin Label ). Patient was hospitalized.

5398135-2 | Gastrointestinal Disorder, Oedema, White Blood Cell Count Increased
Patient was taking Estracyt (View Usage). Patient had the following side effects: gastrointestinal disorder, oedema, white blood cell count increased on Jul 20, 2007 from CHINA Additional patient health information: Male patient , 67 years of age, was diagnosed with prostate cancer stage iv and. Estracyt dosage: . During the same period patient was treated with BISPHOSPHONATES (View Bisphosphonates Review and Bisphosphonates Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), IMMUNOSUPPRESSIVE AGENTS (View Immunosuppressive Agents Review and Immunosuppressive Agents Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5387006-3 | Subileus
Adverse event was reported on Jul 04, 2007 by a Male patient taking Estracyt (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FRANCE , 82 years of age, After Estracyt was administered, patient had the following side effects: subileus. During the same period patient was treated with TRIPTORELIN (View Triptorelin Review and Triptorelin Label ). Patient was hospitalized.

5382262-X | Gastrointestinal Disorder, Oedema, White Blood Cell Count Increased
on Jun 29, 2007 Male patient from CHINA , 67 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder, oedema, white blood cell count increased. Estracyt dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), BISPHOSPHONATES (View Bisphosphonates Review and Bisphosphonates Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ), IMMUNOSUPPRESSIVE AGENTS (View Immunosuppressive Agents Review and Immunosuppressive Agents Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5368038-8 | White Blood Cell Count Increased
on Jun 12, 2007 Male patient from CHINA , 67 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Estracyt (View Usage). Patient had the following side effects: white blood cell count increased. Estracyt dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), BISPHOSPHONATES (View Bisphosphonates Review and Bisphosphonates Label ), CALCIUM CHLORIDE (View Calcium Chloride Review and Calcium Chloride Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), VITAMIN B (View Vitamin B Review and Vitamin B Label ).

5324762-4 | Anorexia, Arthralgia, Asthenia, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cardiac Failure Congestive
Patient was taking Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: anorexia, arthralgia, asthenia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cardiac failure congestive on May 08, 2007 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 123.5 lb, was diagnosed with prostate cancer (What is prostate cancer?), metastases to bone, hypocalcaemia, thrombosis prophylaxis and. Estracyt dosage: . During the same period patient was treated with ETOPOSIDE (50 Mg/day) (View Etoposide Review and Etoposide Label ), ZOMETA (4 Mg Over 30 Minutes) (View Zometa Review and Zometa Label ), ROCALTROL (0.5 Mg/day) (View Rocaltrol Review and Rocaltrol Label ), ASPARTATE CALCIUM (800 G/day) (View Aspartate Calcium Review and Aspartate Calcium Label ), DECADRON (0.5 Mg/day) (View Decadron Review and Decadron Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5313621-9 | Anorexia, Arthralgia, Asthenia, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cardiac Failure Congestive
Adverse event was reported on Apr 23, 2007 by a Male patient taking Estracyt (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?), metastases to bone, hypocalcaemia, thrombosis prophylaxis and. Location: JAPAN , 73 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: anorexia, arthralgia, asthenia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cardiac failure congestive. During the same period patient was treated with ETOPOSIDE (50 Mg/day) (View Etoposide Review and Etoposide Label ), ZOMETA (4 Mg Over 30 Minutes) (View Zometa Review and Zometa Label ), ROCALTROL (0.5 Mg/day) (View Rocaltrol Review and Rocaltrol Label ), ASPARTATE CALCIUM (800 G/day) (View Aspartate Calcium Review and Aspartate Calcium Label ), DECADRON (0.5 Mg/day) (View Decadron Review and Decadron Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5296896-4 | Gynaecomastia, Oedema, Oedema Genital, Weight Increased
on Apr 04, 2007 Male patient from FRANCE , 85 years of age, weighting 169.8 lb, was diagnosed with prostate cancer (What is prostate cancer?), cardiac disorder and was treated with Estracyt (View Usage). Patient had the following side effects: gynaecomastia, oedema, oedema genital, weight increased. Estracyt dosage: Text:4 Df-freq:every Day. During the same period patient was treated with MONO TILDIEM (View Mono-tildiem Review and Mono-tildiem Label ), PREVISCAN (View Previscan Review and Previscan Label ), SERMION (View Sermion Review and Sermion Label ), VASTAREL (View Vastarel Review and Vastarel Label ).

5295966-4 | Arthralgia, Asthenia, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased, Cardiac Failure Congestive
on Apr 02, 2007 Male patient from JAPAN , 73 years of age, weighting 123.5 lb, was diagnosed with prostate cancer (What is prostate cancer?), metastases to bone, hypocalcaemia, thrombosis prophylaxis and was treated with Estracyt (View Usage). After Estracyt was administered, patient had the following side effects: arthralgia, asthenia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cardiac failure congestive. Estracyt dosage: 313.4 Mg/day. During the same period patient was treated with ETOPOSIDE (50 Mg/day) (View Etoposide Review and Etoposide Label ), ZOMETA (4 Mg Over 30 Minutes) (View Zometa Review and Zometa Label ), ROCALTROL (0.5 Mg/day) (View Rocaltrol Review and Rocaltrol Label ), ASPARTATE CALCIUM (800 G/day) (View Aspartate Calcium Review and Aspartate Calcium Label ), DECADRON (0.5 Mg/day) (View Decadron Review and Decadron Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.